• 1
    Head E, McCleary R, Hahn FF, et al. Region-specific age at onset of beta-amyloid in dogs. Neurobiol Aging 2000;21:8996.
  • 2
    Landsberg GM, Nichol J, Araujo JA. Cognitive dysfunction syndrome: A disease of canine and feline brain aging. Vet Clin North Am Small Anim Pract 2012;42:749768.
  • 3
    Osella MC, Re G, Odore R, et al. Canine cognitive dysfunction syndrome: Prevalence, clinical signs and treatment with a neuroprotective nutraceutical. Appl Anim Behav Sci 2007;105:297310.
  • 4
    Azkona G, Garcia-Belenguer S, Chacon G, et al. Prevalence and risk factors of behavioural changes associated with age-related cognitive impairment in geriatric dogs. J Small Anim Pract 2009;50:8791.
  • 5
    Neilson JC, Hart BL, Cliff KD, Ruehl WW. Prevalence of behavioral changes associated with age-related cognitive impairment in dogs. J Am Vet Med Assoc 2001;218:17871791.
  • 6
    Salvin HE, McGreevy PD, Sachdev PS, Valenzuela MJ. Under diagnosis of canine cognitive dysfunction: A cross-sectional survey of older companion dogs. Vet J 2010;184:271281.
  • 7
    Adams B, Chan A, Callahan H, et al. Use of a delayed non-matching to position task to model age-dependent cognitive decline in the dog. Behav Brain Res 2000;108:4756.
  • 8
    Bain MJ, Hart BL, Cliff KD, Ruehl WW. Predicting behavioral changes associated with age-related cognitive impairment in dogs. J Am Vet Med Assoc 2001;218:17921795.
  • 9
    Milgram NW, Head E, Weiner E, Thomas E. Cognitive functions and aging in the dog: Acquisition of nonspatial visual tasks. Behav Neurosci 1994;108:5768.
  • 10
    Johnstone EM, Chaney MO, Norris FH, et al. Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. Brain Res Mol Brain Res 1991;10:299305.
  • 11
    Sarasa L, Gallego C, Monleón I, et al. Cloning, sequencing and expression in the dog of the main amyloid precursor protein isoforms and some of the enzymes related with their processing. Neuroscience 2010;171:10911101.
  • 12
    Head E, Callahan H, Muggenburg BA, et al. Visual-discrimination learning ability and beta-amyloid accumulation in the dog. Neurobiol Aging 1998;19:415425.
  • 13
    Colle MA, Hauw JJ, Crespeau F, et al. Vascular and parenchymal Abeta deposition in the aging dog: Correlation with behavior. Neurobiol Aging 2000;21:695704.
  • 14
    Rofina JE, van Ederen AM, Toussaint MJM, et al. Cognitive disturbances in old dogs suffering from the canine counterpart of Alzheimer's disease. Brain Res 2006;1069:216226.
  • 15
    Cummings BJ, Head E, Afagh AJ, et al. Beta-amyloid accumulation correlates with cognitive dysfunction in the aged canine. Neurobiol Learn Mem 1996;66:1123.
  • 16
    Hasegawa D, Yayoshi N, Fujita Y, et al. Measurement of interthalamic adhesion thickness as a criteria for brain atrophy in dogs with and without cognitive dysfunction (dementia). Vet Radiol Ultrasound 2005;46:452457.
  • 17
    Tapp PD, Siwak CT, Gao FQ, et al. Frontal lobe volume, function, and beta-amyloid pathology in a canine model of aging. J Neurosci 2004;24:82058213.
  • 18
    Grammas P, Samany PG, Thirumangalakudi L. Thrombin and inflammatory proteins are elevated in Alzheimer's disease microvessels: Implications for disease pathogenesis. J Alzheimers Dis 2006;9:5158.
  • 19
    Skoumalova A, Rofina J, Schwippelova Z, et al. The role of free radicals in canine counterpart of senile dementia of the Alzheimer type. Exp Gerontol 2003;38:711719.
  • 20
    Rinaldi P, Polidori MC, Metastasio A, et al. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol Aging 2003;24:915919.
  • 21
    McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:263269.
  • 22
    Snyder PJ, Jackson CE, Petersen RC, et al. Assessment of cognition in mild cognitive impairment: A comparative study. Alzheimers Dement 2011;7:338355.
  • 23
    Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:280292.
  • 24
    Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:270279.
  • 25
    Kiatipattanasakul W, Nakamura S, Hossain MM, et al. Apoptosis in the aged dog brain. Acta Neuropathol 1996;92:242248.
  • 26
    Gallagher D, Coen R, Kilroy D, et al. Anxiety and behavioural disturbance as markers of prodromal Alzheimer's disease in patients with mild cognitive impairment. Int J Geriatr Psychiatry 2011;26:166172.
  • 27
    Mega MS, Cummings JL, Fiorello T, Gornbein J. The spectrum of behavioral changes in Alzheimer's disease. Neurology 1996;46:130135.
  • 28
    Morris JC, Edland S, Clark C, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 1993;43:24572465.
  • 29
    Pugliese M, Carrasco JL, Andrade C, et al. Severe cognitive impairment correlates with higher cerebrospinal fluid levels of lactate and pyruvate in a canine model of senile dementia. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:603610.
  • 30
    Salvin HE, McGreevy PD, Sachdev PS, Valenzuela MJ. The canine cognitive dysfunction rating scale (CCDR): A data-driven and ecologically relevant assessment tool. Vet J 2011;188:331336.
  • 31
    Hart BL. Effect of gonadectomy on subsequent development of age-related cognitive impairment in dogs. J Am Vet Med Assoc 2001;219:5156.
  • 32
    Campbell S, Trettien A, Kozan B. A noncomparative open-label study evaluating the effect of selegiline hydrochloride in a clinical setting. Vet Ther 2001;2:2439.
  • 33
    Milgram NW, Head E, Zicker SC, et al. Long-term treatment with antioxidants and a program of behavioral enrichment reduces age-dependent impairment in discrimination and reversal learning in Beagle dogs. Exp Gerontol 2004;39:753765.
  • 34
    Landsberg GM, DePorter T, Araujo JA. Clinical signs and management of anxiety, sleeplessness, and cognitive dysfunction in the senior pet. Vet Clin North Am Small Anim Pract 2011;41:565590.
  • 35
    Takeuchi T, Harada E. Age-related changes in sleep-wake rhythm in dog. Behav Brain Res 2002;136:193199.
  • 36
    Volicer L, Harper DG, Manning BC, et al. Sundowning and circadian rhythms in Alzheimer's disease. Am J Psychiatry 2001;158:704711.
  • 37
    Holtzer R, Tang MX, Devanand DP, et al. Psychopathological features in Alzheimer's disease: Course and relationship with cognitive status. J Am Geriatr Soc 2003;51:953960.
  • 38
    Chapman BL, Voith VL. Behavioral problems in old dogs: 26 cases (1984–1987). J Am Vet Med Assoc 1990;196:944946.
  • 39
    Porter VR, Buxton WG, Fairbanks LA, et al. Frequency and characteristics of anxiety among patients with Alzheimer's disease and related dementias. J Neuropsychiatry Clin Neurosci 2003;15:180186.
  • 40
    McCurry SM, Gibbons LE, Logsdon RG, Teri L. Anxiety and nighttime behavioral disturbances. Awakenings in patients with Alzheimer's disease. J Gerontol Nurs 2004;30:1220.
  • 41
    Guariglia CC, Nitrini R. Topographical disorientation in Alzheimer's disease. Arq Neuropsiquiatr 2009;67:967972.
  • 42
    Ravetz RS. Psychiatric disorders associated with Alzheimer's disease. J Am Osteopath Assoc 1999;99(9 Suppl):S13S16.
  • 43
    Ganguli M, Dodge HH, Shen C, DeKosky ST. Mild cognitive impairment, amnestic type: An epidemiologic study. Neurology 2004;63:115121.
  • 44
    Ritchie K. Mild cognitive impairment: An epidemiological perspective. Dialogues Clin Neurosci 2004;6:401408.
  • 45
    Winblad B, Wimo A, Engedal K, et al. 3-year study of donepezil therapy in Alzheimer's disease: Effects of early and continuous therapy. Dement Geriatr Cogn Disord 2006;21:353363.
  • 46
    Proschowsky HF, Rugbjerg H, Ersboll AK. Mortality of purebred and mixed-breed dogs in Denmark. Prev Vet Med 2003;58:6374.
  • 47
    Michell AR. Longevity of British breeds of dog and its relationships with sex, size, cardiovascular variables and disease. Vet Rec 1999;145:625629.
  • 48
    Patronek GJ, Waters DJ, Glickman LT. Comparative longevity of pet dogs and humans: Implications for gerontology research. J Gerontol A Biol Sci Med Sci 1997;52A:B171B178.